Hantz Financial Services’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,612
Closed -$1K 2564
2025
Q3
$1K Sell
7,612
-100
-1% -$13 ﹤0.01% 2301
2025
Q2
$0 Hold
7,712
﹤0.01% 2330
2025
Q1
$0 Hold
7,712
﹤0.01% 2025
2024
Q4
$1K Hold
7,712
﹤0.01% 1076
2024
Q3
$1K Buy
7,712
+100
+1% +$14 ﹤0.01% 1059
2024
Q2
$1K Hold
7,612
﹤0.01% 1047
2024
Q1
$1K Hold
7,612
﹤0.01% 1180
2023
Q4
$2K Hold
7,612
﹤0.01% 1052
2023
Q3
$1K Hold
7,612
﹤0.01% 1104
2023
Q2
$2K Hold
7,612
﹤0.01% 1011
2023
Q1
$2K Hold
7,612
﹤0.01% 1023
2022
Q4
$1K Hold
7,612
﹤0.01% 1061
2022
Q3
$2K Hold
7,612
﹤0.01% 992
2022
Q2
$2K Hold
7,612
﹤0.01% 969
2022
Q1
$3K Buy
+7,612
New +$2.49K ﹤0.01% 944

Other funds holding ZOM

Hantz Financial Services's ZOM Position: Q4 2025 in Review

Hantz Financial Services sold out of Zomedica Corp. (ZOM) in Q4 2025, closing a stake of 7,612 shares — an estimated $1K sold.

Hantz Financial Services first reported a position in ZOM in Q1 2022 and held it in 15 quarters. The position peaked at $3K in Q1 2022. 7 funds tracked by Wall St. Rank hold ZOM as of Q4 2025.

  • Hantz Financial Services reported no remaining Zomedica Corp. position as of Q4 2025 after selling out during the quarter.
  • Hantz Financial Services sold 7,612 Zomedica Corp. shares in Q4 2025, an estimated $1K.
  • Hantz Financial Services first reported a position in Zomedica Corp. in Q1 2022 and held it in 15 quarters.
  • Hantz Financial Services's Zomedica Corp. position peaked at $3K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2025.

Based on Hantz Financial Services's 13F filing for Q4 2025, filed 9 Feb 2026.